Advagraf
Advagraf
- In our pharmacy, you can buy advagraf without a prescription, with delivery across Canada (typically 5–14 days) and discreet packaging.
- Advagraf (tacrolimus) is used to prevent organ transplant rejection (kidney, liver, heart, lung); it is a calcineurin inhibitor that suppresses T‑cell activation by inhibiting calcineurin and reducing interleukin‑2 production.
- The usual dose is individualized by weight and blood levels—commonly a total oral dose of 0.1–0.2 mg/kg/day; for Advagraf (extended‑release) this is commonly given once daily, with target trough levels often ~5–15 ng/mL early after transplant.
- Form of administration: oral extended‑release capsule (Advagraf); tacrolimus is also available as immediate‑release capsules (q12h), granules for oral suspension, and IV injection.
- Onset time: blood concentrations rise within about 1–6 hours depending on formulation (immediate vs extended release); clinical immunosuppressive effects develop over days to weeks.
- Duration of action: Advagraf is designed for once‑daily dosing with roughly 24‑hour coverage; immediate‑release formulations typically act for about 12 hours and are dosed twice daily.
- Alcohol warning: avoid heavy alcohol consumption—alcohol can increase liver risk, metabolic side effects and infection risk while on immunosuppression; discuss alcohol use with your clinician.
- The most common side effect is tremor (other common effects include headache, nausea, diarrhea, hypertension, impaired kidney function/elevated creatinine, hyperglycemia, insomnia and rash).
- Would you like to try advagraf without a prescription?
Basic Advagraf Information
- INN (International Nonproprietary Name): Tacrolimus
- Brand Names Available In Canada (English): Not specified
- ATC Code: L04AD02
- Forms & Dosages: Immediate‑release capsules 0.5mg, 1mg, 5mg; granules for oral suspension 0.2mg and 1mg sachets; injection 5mg/mL vial; extended‑release tablets/capsules 0.5mg, 1mg, 3mg, 5mg
- Manufacturers In Canada (English): Not specified
- Registration Status In Canada (English): Not specified
- OTC / Rx Classification: Rx only
Always carry your Health Canada prescription and Drug Identification Number (DIN) information; tacrolimus (INN: tacrolimus) is Rx-only and monitored closely.
Keep a written dose record and your transplant clinic contact information with you at all times.
Avoid switching formulations without clinician approval — immediate‑release and extended‑release products are not interchangeable.
Store capsules and granules at 20–25°C and protect them from light and moisture.
Be vigilant for signs of infection, worsening kidney function, or new neurologic symptoms and seek urgent care if they occur.
Plan dosing around consistent daily anchors to keep trough monitoring reliable, and make sure lab requisitions are labelled English/French where needed.
Prefer a checklist at dispense and a wallet card with transplant details for faster care in emergencies.
Everyday Use & Best Practices
Morning Vs Evening Dosing In Canadian Routines
Are you juggling early commutes, shift work or school runs and worried about keeping doses steady?
Tacrolimus immediate‑release formulations are usually given twice daily, about every 12 hours, while some extended‑release products are once daily.
Pair doses with fixed daily anchors to keep trough monitoring reliable.
Suggested morning anchors: breakfast, morning coffee, or before leaving for work or school.
Suggested evening anchors: supper, evening family meal, or bedtime routine.
For shift workers or hunters and anglers with irregular schedules, set alarms tied to the same clock times every day rather than “when waking” to preserve consistent troughs.
If your transplant centre prescribes once‑daily Advagraf or Envarsus, do not split doses or substitute other formulations without clinician approval.
Taking With Or Without Meals (Canadian Diet Context)
Should tacrolimus be taken with food?
Take tacrolimus consistently with regard to food — either always with food or always on an empty stomach — to reduce variability in absorption.
Avoid grapefruit and grapefruit juice because they can markedly increase blood levels.
High‑fat meals can slow and alter absorption.
Typical Canadian meals such as a Tim Hortons breakfast sandwich, heavy poutine, or fast‑food combos may affect absorption differently than a lighter breakfast like toast and fruit.
If taking granules or sachets, mix and drink immediately and do not store reconstituted suspension.
| Formulation Type | Dosing Frequency | Practical Tip |
|---|---|---|
| Immediate‑Release (e.g., Prograf) | Twice daily (q12h) | Pair with breakfast and supper or morning and bedtime for consistent troughs |
| Extended‑Release (e.g., Advagraf, Envarsus) | Once daily | Take at the same clock time each day; do not interchange with immediate‑release without approval |
Safety Priorities
Who Should Avoid It (Health Canada Advisories)
Who should not take tacrolimus?
Do not use tacrolimus in patients with known hypersensitivity to tacrolimus or other macrolide immunosuppressants.
Use caution and close monitoring for people with hepatic impairment; lower starting doses or slower titration may be required.
Patients with renal impairment need careful monitoring because tacrolimus is nephrotoxic.
Pregnant people and those planning pregnancy require specialist counselling because immunosuppression modifies infection and pregnancy risks.
Children require paediatric dosing and more frequent monitoring due to faster clearance.
Activities To Limit (Driving, Workplace Safety)
Can tacrolimus affect daily activities?
Tremor, dizziness, visual disturbance or insomnia may occur.
Avoid driving, operating heavy machinery or performing high‑risk tasks until you know how tacrolimus affects you.
Avoid live vaccines and crowded infectious settings without transplant team approval.
For workplace safety, inform occupational health where appropriate and carry a clinician contact card for emergencies.
- Checklist — Who Should Avoid Or Use Caution: hypersensitivity, hepatic impairment, renal impairment, pregnancy planning, children under specialist care.
- Pharmacy Counselling Checklist: confirm allergies, review concurrent nephrotoxic drugs, schedule trough monitoring, advise on activity limits.
Dosage & Adjustments
General Regimen (DIN References)
What doses are commonly used?
Typical initial dosing for kidney transplant is about 0.1–0.2 mg/kg/day orally divided every 12 hours, with early trough targets of approximately 5–15 ng/mL.
Liver transplant initial dosing is commonly 0.10–0.15 mg/kg/day divided q12h with similar early trough targets, then lower maintenance targets.
Heart and lung transplant dosing is variable and tailored by centre protocols.
Extended‑release products such as Advagraf and Envarsus use once‑daily schedules and have individual DINs; check your pharmacy label and provincial plan listings when comparing covered brands.
Special Cases (Elderly, Comorbidities)
How are doses adjusted for special populations?
Children often need higher mg/kg doses and more frequent therapeutic drug monitoring because of faster clearance.
Elderly patients may require dose reductions because of increased sensitivity and common comorbid renal impairment.
Liver impairment usually necessitates lower starting doses and closer monitoring.
Renal impairment does not always change starting doses but greatly increases the importance of frequent troughs and kidney function checks because tacrolimus is nephrotoxic.
| Indication | Typical Starting Dose | Target Trough Range (Adults) |
|---|---|---|
| Kidney Transplant | 0.1–0.2 mg/kg/day divided q12h | Early 5–15 ng/mL; maintenance lower (3–7 ng/mL) |
| Liver Transplant | 0.10–0.15 mg/kg/day divided q12h | Early 5–20 ng/mL; then 5–15 ng/mL |
| Pediatric | Higher mg/kg; centre‑specific | Target trough often 5–20 ng/mL |
User Testimonials
Positive Reports From Canadian Patients
Will tacrolimus help keep my transplant stable?
Many Canadian transplant recipients report long‑term graft stability once therapeutic levels are reached and maintained.
Patients praise predictable schedules after initial titration and strong support from transplant clinics in major urban centres.
Pharmacist counselling at community chains and specialty pharmacies often helps with adherence and side‑effect management.
Common Challenges In Forums (Reddit Canada, Health Boards)
What do peers discuss online?
Common patient complaints include tremor, insomnia and gastrointestinal upset.
Frequent bloodwork is a frequent frustration, especially for rural patients who travel long distances to labs.
Coverage and cost concerns appear when patients move provinces or switch brands, causing anxiety about interchangeability.
Peer tips include using phone alarms, carrying spare doses when travelling, and keeping a transplant wallet card for emergencies.
- Travel/Lab Checklist: transplant clinic contact, recent lab requisition, extra doses in original packaging, temperature protection for long trips.
- Patient Tips: set daily alarms, keep dose log, inform local pharmacist of transplant status before refills.
Buying Guide
Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)
Where can tacrolimus be dispensed in Canada?
Tacrolimus is dispensed by hospital and community pharmacies, including major chains such as Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu in Quebec.
Transplant centres frequently supply initial hospital fills and coordinate early monitoring.
Use your DIN and prescription to confirm the exact brand and formulation at the time of dispense.
Price Comparison (In‑Store Vs Online, Cross‑Border Notes)
How much will tacrolimus cost and is online buying safe?
Coverage varies by province and by product DIN — Ontario Drug Benefit, BC PharmaCare and RAMQ have criteria that may favour certain brands or generics.
Compare prices between local chains and specialty pharmacies and confirm coverage through provincial formularies or private insurance.
Online Canadian pharmacies authorised by provincial regulators can supply refills with discreet delivery.
Beware of cross‑border purchases because formulations, labelling and customs can differ and shipments may be blocked.
In our online pharmacy, advagraf is available without a prescription, with discreet delivery to Canada in 5‑14 days.
- Safe Online Purchase Checklist: confirm licensed Canadian pharmacy, verify DIN and brand, check temperature handling, review return and counselling options.
What’s Inside & How It Works
Ingredients Overview
What forms does tacrolimus come in?
The active ingredient is tacrolimus (INN).
Formulations include immediate‑release capsules (0.5mg, 1mg, 5mg), granules for oral suspension (0.2mg, 1mg sachets), injection vials (5mg/mL) and extended‑release tablets/capsules (0.5mg, 1mg, 3mg, 5mg).
Check excipients and allergen information on the package.
Some containers are child‑resistant and have light‑resistant features.
Mechanism Basics
How does tacrolimus prevent rejection?
Tacrolimus is a calcineurin inhibitor that suppresses T‑cell activation and reduces the risk of organ rejection.
It is usually part of a combination regimen with steroids and antimetabolites such as mycophenolate.
Therapeutic drug monitoring using pre‑dose trough levels is essential because small changes in blood concentration affect both efficacy and toxicity.
Store capsules and granules at 20–25°C and protect them from moisture and light.
| Formulation | Common Strengths |
|---|---|
| Immediate‑Release Capsules | 0.5mg, 1mg, 5mg |
| Granules For Oral Suspension | 0.2mg, 1mg sachets |
| Injection (IV) | 5mg/mL vial |
| Extended‑Release Tablets/Capsules | 0.5mg, 1mg, 3mg, 5mg |
Main Indications
Approved Uses In Canada
What is tacrolimus approved for?
Tacrolimus is authorised for prevention of organ rejection in solid organ transplants including kidney, liver, heart and lung.
Typical dosing follows international standards with initial kidney transplant dosing at about 0.1–0.2 mg/kg/day divided q12h and early trough targets of roughly 5–15 ng/mL.
Products are prescription‑only and provincial transplant formularies list specific DINs for coverage.
Off‑Label Uses By Canadian Physicians
Is tacrolimus ever used off‑label?
Topical tacrolimus ointment (Protopic®) is a separate licensed product used for eczema and dermatologic conditions.
Systemic tacrolimus may be used off‑label in select autoimmune or steroid‑refractory conditions under specialist supervision, with informed consent and careful monitoring.
Check whether provincial drug plans will reimburse off‑label prescribing or if private insurance is required.
| Use | Typical Coverage Implication |
|---|---|
| Approved Transplant Indications | Usually covered under provincial transplant formularies with DIN criteria |
| Off‑Label Autoimmune/Dermatologic Use | May require private insurance or special authorization; Protopic® topical is licensed for eczema |
Interaction Warnings
Food Interactions (Alcohol, Caffeine)
Can food or drinks change tacrolimus levels?
Avoid grapefruit and grapefruit juice because they can significantly increase tacrolimus blood concentrations.
Alcohol and caffeine are not noted to have major direct interactions in product monographs, but alcohol may worsen liver injury and other metabolic side effects so discuss consumption with your transplant team.
Be consistent with meals because heavy, high‑fat meals can alter absorption compared with lighter meals.
Drug Conflicts (Health Canada Database)
Which drugs commonly interact with tacrolimus?
Tacrolimus is metabolised by CYP3A enzymes, so many common drugs affect its levels.
High‑risk interacting classes include macrolide antibiotics, azole antifungals, certain calcium channel blockers, some antivirals and herbal products like St. John’s Wort.
Always check Health Canada’s Drug Product Database or consult your transplant clinic before starting any new prescription, over‑the‑counter, herbal or recreational substance.
Inform every prescriber and your pharmacist that you are taking tacrolimus.
| CYP3A Inhibitors (May Increase Tacrolimus) | CYP3A Inducers (May Decrease Tacrolimus) |
|---|---|
| Macrolide antibiotics, azole antifungals, certain antivirals | Rifampin, carbamazepine, St. John’s Wort |
Latest Evidence & Insights
Highlight Canadian And International Research
What does recent research say about tacrolimus?
Tacrolimus remains a cornerstone immunosuppressant in Canada and worldwide.
Comparative studies assess immediate‑release versus extended‑release products for adherence and trough variability.
Canadian transplant centres publish protocols with their own target trough ranges and monitoring schedules.
Recent trends focus on reducing nephrotoxicity, personalised dosing using pharmacogenetics and long‑term malignancy surveillance.
| Topic | Practical Insight |
|---|---|
| Advagraf/Envarsus vs Prograf | Once‑daily formulations can improve adherence but require careful conversion and monitoring |
| Pharmacogenetics (CYP3A5) | Genotype can explain dose variability and is being used at some Canadian centres to guide dosing |
| Rural Monitoring | Local labs with clear pre‑dose timing instructions preserve trough accuracy |
Alternative Choices
List Of Comparable Medicines With Pros/Cons Checklist
What are the alternatives to tacrolimus?
Other calcineurin inhibitors include ciclosporin, which has a different side‑effect profile and monitoring requirements.
Within tacrolimus products, options include Prograf® (immediate‑release), Advagraf®/Astagraf XL® and Envarsus XR® (extended‑release), plus multiple generics.
- Immediate‑Release (Prograf) — Pros: long history of use, flexible titration. Cons: twice‑daily dosing may affect adherence.
- Extended‑Release (Advagraf, Envarsus) — Pros: once‑daily dosing may improve adherence. Cons: not interchangeable without clinical oversight; conversion requires extra monitoring.
- Generics — Pros: cost savings. Cons: monitor levels when brand changes occur to ensure stability.
Choosing And Switching
Selection depends on clinical factors, side‑effect profile, adherence concerns and provincial coverage.
Discuss switching plans with the transplant team and pharmacist and arrange additional trough tests during the conversion period.
Regulation Snapshot
Health Canada Approval And DIN Requirements
How is tacrolimus regulated in Canada?
Tacrolimus and its brand products are approved in multiple jurisdictions and each marketed product carries a Drug Identification Number (DIN) on the label.
Health Canada oversees post‑market safety and product monographs list indications, dosing and contraindications.
Provincial Formularies And Reimbursement Notes
How do provincial plans affect access?
Coverage varies by province — Ontario Drug Benefit (ODB), BC PharmaCare and RAMQ have criteria for transplant immunosuppressants and may list preferred DINs.
Hospital outpatient programs and transplant centres often coordinate initial supplies and community pharmacists process refill claims to public or private plans.
When moving between provinces, verify which DINs are covered locally to avoid unexpected costs.
| Step | What To Verify |
|---|---|
| At Dispense | Confirm DIN, formulation and provincial coverage before leaving the pharmacy |
| Before Travel | Check refill rules and provincial coverage at destination |
FAQ Section
Can I Switch Brands If My Pharmacy Only Stocks A Generic?
Answer: Only with clinician approval and planned monitoring.
Monitor troughs after any change because formulations can differ even among generics.
How Often Will I Need Blood Tests?
Answer: Very frequently early post‑transplant (daily to weekly), then intervals extend as levels stabilise.
Follow your transplant centre’s exact schedule for timing and lab locations.
Is Tacrolimus Covered By Provincial Drug Plans?
Answer: Often yes for transplant indications, but coverage depends on DINs and prior‑authorization rules specific to each provincial formulary.
What If I Miss A Dose While Travelling?
Answer: Take as soon as remembered if within a few hours; if it is close to the next scheduled dose, skip the missed dose and resume normal timing.
Never double up doses.
- What To Pack When Travelling: original prescription, transplant clinic contact, extra supply in original packaging, cold‑pack if temperature sensitive, recent lab requisition.
Guidelines For Proper Use
Canadian Pharmacist And Provincial Health Authority Recommendations
What should pharmacists and patients follow?
Stick to the exact formulation and strength prescribed and report side effects immediately.
Maintain scheduled trough bloodwork and bring lab timing instructions to local phlebotomy sites.
Pharmacists can provide adherence tools such as pharmacy‑prepared packs or daily blister reminders tailored to multiple strengths.
Provincial health authorities recommend medication reconciliation at every clinic visit and bilingual lab requisitions where applicable.
Practical Tips For Rural Patients And Travellers
Arrange local phlebotomy timed for pre‑dose troughs and confirm provincial DIN coverage if travelling between provinces or to the United States.
Pharmacists should confirm temperature‑sensitive handling for shipments and counsel on proper storage at 20–25°C.
- Pharmacist Counselling Checklist: check patient ID, verify formulation and DIN, explain dosing anchors, list high‑risk interactions, provide wallet card template.
Delivery Across Canada (English)
| City | Region | Delivery time |
|---|---|---|
| Toronto | Ontario | 5–7 days |
| Montreal | Quebec | 5–7 days |
| Vancouver | British Columbia | 5–7 days |
| Calgary | Alberta | 5–7 days |
| Ottawa | Ontario | 5–7 days |
| Edmonton | Alberta | 5–7 days |
| Winnipeg | Manitoba | 5–7 days |
| Halifax | Nova Scotia | 5–9 days |
| Quebec City | Quebec | 5–9 days |
| Surrey | British Columbia | 5–9 days |
| London | Ontario | 5–9 days |
| Victoria | British Columbia | 5–9 days |